Live Currency Rates
 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

US firm won't enforce AIDS drug patents in poor countries  Join our daily free Newsletter

MENAFN - AFP - 29/11/2012

No. of Ratings : 0
Add to Mixx!


 


(MENAFN - AFP) Pharmaceutical giant Johnson & Johnson announced Thursday that it would not enforce its patents on its AIDS drug Prezista in the world's poorest countries and throughout sub-Saharan Africa.

Offering cost relief to people infected with the HIV virus, J&J said it wanted to assure manufacturers that they can freely produce the generic version of the drug, darunavir, for sale in poor countries without fear of being accused of patent violation.

The new policy applies only to countries defined by the United Nations as Least Developed Countries, and also to sub-Saharan Africa, where the AIDS epidemic has been most intense.

"This new policy anticipates a greater future need to supply affordable generic versions of darunavir for the treatment of people living with HIV in the territory," J&J said, two days ahead of the annual World AIDS Day.

"We believe... that intellectual property should not be a barrier to ensuring a sustainable supply of medically acceptable darunavir in the world's poorest countries," Paul Stoffels, J&J's worldwide chairman for pharmaceuticals, said in a statement.

J&J markets the antiretroviral drug as Prezista through its subsidiary Janssen Pharmaceuticals.

It is often administered together with other antiretroviral drugs, like the already widely available ritonavir, to protect HIV-infected patients from developing full-blown AIDS.

At the official US wholesale price, Prezista costs a user more than 34 a day or some 12,400 a year.

As a generic, though, the price can drop by 90 percent or more, Stoffels told AFP. Darunavir is currently produced by South Africa's Aspen Pharmaceuticals and sold locally for about 2.22 a dose, he said.

Stoffels said he expected the demand for darunavir to soar, with production launched in 10-15 factories worldwide to supply poor countries covered under the new patent protection announcement.


 






  MENA News Headlines


 
Live Currency Rates






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help